Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hospice × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 198 Lymphoma 44 Leukemia 43 Multiple Myeloma 41 Leukemia, Lymphocytic, Chronic, B-Cell 39 Neoplasms, Plasma Cell 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Monoclonal Gammopathy of Undetermined Significance 35 Lymphoma, Non-Hodgkin 35 Lymphoma, Mantle-Cell 34 Lymphoma, Large-Cell, Immunoblastic 34 Lymphoma, Large B-Cell, Diffuse 34 Lymphoma, Follicular 34 Myelodysplastic Syndromes 33 Leukemia, Myeloid, Acute 33 Burkitt Lymphoma 33 Myeloproliferative Disorders 32 Lymphoma, B-Cell, Marginal Zone 32 Hodgkin Disease 32 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 31 Immunoglobulin Light-chain Amyloidosis 30 Waldenstrom Macroglobulinemia 29 Uterine Cervical Neoplasms 29 Immunoblastic Lymphadenopathy 29 Primary Myelofibrosis 28 Lymphoma, Large-Cell, Anaplastic 28 Thrombocythemia, Essential 27 Lymphoma, T-Cell, Cutaneous 27 Leukemia, Biphenotypic, Acute 27 Uterine Cervical Dysplasia 26

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡